Jason Westin, MD

Articles by Jason Westin, MD

Jason Westin, MD, on the Phase III ZUMA-7 Primary OS Analysis

Jason Westin, MDAggressive B-Cell Lymphoma | September 5, 2023

The study compared axicabtagene ciloleucel with standard‑of‑care therapy in patients with relapsed or refractory LBCL.